Management of Severe Hypertension in Postpartum Pre-eclampsia

Initial Assessment and Management

Severe hypertension (BP ≥160/110 mmHg) in postpartum pre-eclampsia requires immediate treatment to prevent complications such as stroke, pulmonary edema, and eclampsia 1, 2
The goal is to lower BP within 150-180 minutes to prevent hypertensive complications in the mother 3
Target blood pressure should be <160/105 mmHg 1, 2

Switch to intravenous labetalol or nicardipine as first-line treatment for hypertensive crisis in pre-eclampsia 4, 5
If IV access is difficult, oral nifedipine can be continued but with increased dosing as needed 6
Administer magnesium sulfate: 4 g IV over 5 minutes, then 1 g/h IV infusion, or 5 g intramuscularly into each buttock, then 5 g IM every 4 hours 7
Magnesium sulfate is essential for prevention of eclampsia 8, 9

Check BP and clinical condition at least every 4 hours while awake for at least 3 days postpartum 10
Monitor for signs of end-organ damage (neurological symptoms, oliguria, pulmonary edema) 3
Consider adding a third agent if BP control not achieved within 360 minutes with two medications 7
IV labetalol: Start with 20 mg IV bolus, then 20-80 mg every 10-30 minutes or continuous infusion 2
IV nicardipine: 5 mg/h, increasing by 2.5 mg/h every 5-15 minutes to maximum 15 mg/h 2

Avoid concomitant administration of nifedipine and magnesium sulfate due to risk of hypotension 7
Avoid diuretics as plasma volume is reduced in pre-eclampsia 7
If BP control is not achieved despite two medications at adequate doses within 360 minutes, consult critical care for ICU admission 7
Monitor for maternal early warning signs: tachycardia, oliguria, changed mental status, shortness of breath 3

Continue antihypertensive therapy postpartum; do not cease abruptly 10
Avoid NSAIDs for postpartum analgesia to prevent renal complications 10
Review at 3 months postpartum to ensure BP, urinalysis, and laboratory abnormalities have normalized 10
Annual medical review is advised lifelong due to increased future cardiovascular risk 10